Pilot Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Intervention: Biological: Intravitreal autologous CD34+ cells Sponsors: University of California, Davis; Cures Within Reach Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials